Abstract

The steady improvement and optimization of transdermal permeation is a constant and challenging pharmaceutical task. In this study the influence of poly(lactide-co-glycolide) (PLGA) nanoparticles on the dermal permeation of the anti-inflammatory drug flufenamic acid (FFA) was investigated. For this aim, different vehicles under non-buffered and buffered conditions and different skin models (human heat separated epidermis and reconstructed human epidermis equivalents) were tested. Permeation experiments were performed using static Franz diffusion cells under infinite dosing conditions. Already the presence of drug-free nanoparticles increased drug permeation across the skin. Drug permeation was even enhanced when applying drug-loaded nanoparticles. In contrast, buffered vehicles with different pH values (pH 5.4–7.4) revealed the influence of the pH on the permeation of FFA. The change of the surrounding pH of the biodegradable nanoparticulate system was demonstrated and visualized using pH-sensitive fluorescent probes. While a potential contribution of hair follicles could be ruled out, our data suggest that the enhanced permeation of FFA through human skin in the presence of PLGA nanoparticles is mediated by a locally decreased pH during hydrolytic degradation of this polymer. This hypothesis is supported by the observation that skin permeation of the weak base caffeine was not affected.

Highlights

  • Published: 3 October 2021The skin, due to the structure and composition of the stratum corneum, provides a highly impermeable barrier of the human body against the environment

  • In comparison to other drugs in solution, the permeation of the anti-inflammatory drug flufenamic acid encapsulated into poly(lactide-co-glycolide) nanoparticles (PLGA-NP) through human skin was improved [7]

  • Infinite dose permeation experiments using unbuffered hydrogels containing dissolved flufenamic acid (FFA), either in presence or absence of drug-free NP or FFA encapsulated into nanoparticles (NPs), were performed in vitro to investigate the influence of

Read more

Summary

Introduction

Published: 3 October 2021The skin, due to the structure and composition of the stratum corneum, provides a highly impermeable barrier of the human body against the environment. Several strategies to improve the transdermal delivery of active pharmaceutical ingredients have been investigated e.g., by means of physical/mechanical enhancement, by supersaturated formulations, ionto- and sonophoresis, electroporation, microneedles, chemical penetration enhancers and nanosized drug delivery systems [1,2]. Nowadays, nanosized drug delivery systems have gained a broad attention for use in dermal/transdermal delivery due to the possibility of delivering the active compound in a controlled manner to or across skin [3,4,5,6]. In comparison to other drugs in solution, the permeation of the anti-inflammatory drug flufenamic acid encapsulated into poly(lactide-co-glycolide) nanoparticles (PLGA-NP) through human skin was improved [7]. In contrast to reports of Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call